MRI-guided laser ablation system receives CE Mark approval

13th April 2018
Source: Medtronic
Posted By : Enaie Azambuja
MRI-guided laser ablation system receives CE Mark approval

Medtronic plc has announced the CE (Conformité Européenne) Mark and European launch of the Visualase MRI-Guided Laser Ablation System. The Visualase system provides advanced MRI-guided laser ablation technology and can be used in neurosurgery procedures. With the Visualase system, laser energy is delivered to the target area using an applicator. As light is delivered through the applicator, temperatures in the target area begin to rise, destroying the unwanted soft tissue.

Because Visualase procedures are guided by MRI images, the procedure can provide precise and controlled ablation. Due to the minimally invasive nature of the procedure, patients typically go home the next day.

"The Visualase system will give neurosurgeons an additional minimally invasive option to precisely target and treat small areas of tissue," said Professor Jürgen Voges, M.D., from Magdeburg, Germany. "We are looking forward to offering this procedure to our patients."

The Visualase MRI-Guided Laser Ablation System received FDA clearance in the United States in July 2007 to necrotise or coagulate soft tissue. Medtronic is currently involved in a pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) study in the United States to support an expanded FDA indication for the treatment of epilepsy in patients with drug-resistant mesial temporal lobe epilepsy (MTLE), the most common form of partial or localisation related epilepsy.

"After supporting the FDA clearance with our completion of the first in-human study of the Visualase system in 2006 in Paris, I am excited the technology has arrived in Europe," said Professor Alexandre C. Carpentier, neurosurgeon from Pitie Salpetriere university hospital, Greater Paris University Hospitals - AP-HP of Paris, France.

"The introduction of Visualase to European physicians ensures that more patients will have access to this beneficial technology," said Brett Wall, senior vice president and president of Medtronic's Brain Therapies division, which is part of the Restorative Therapies Group. "This latest milestone is a testament to our commitment to expanding therapeutic options for physicians and their patients."

Downloads


You must be logged in to comment

Write a comment

No comments




Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

IoT Solutions World Congress 2018
16th October 2018
Spain Barcelona
Engineering Design Show 2018
17th October 2018
United Kingdom Ricoh Arena, Coventry
Maintec 2018
6th November 2018
United Kingdom NEC, Birmingham
electronica 2018
13th November 2018
Germany Messe Munchen
SPS IPC Drives 2018
27th November 2018
Germany Nuremberg